The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-Bromo-9H-carbazol-9-yl)-N-(3-methoxybenzyl)-N-methylacetamide ID: ALA4518499
PubChem CID: 155541492
Max Phase: Preclinical
Molecular Formula: C23H21BrN2O2
Molecular Weight: 437.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(CN(C)C(=O)Cn2c3ccccc3c3cc(Br)ccc32)c1
Standard InChI: InChI=1S/C23H21BrN2O2/c1-25(14-16-6-5-7-18(12-16)28-2)23(27)15-26-21-9-4-3-8-19(21)20-13-17(24)10-11-22(20)26/h3-13H,14-15H2,1-2H3
Standard InChI Key: CDLCLZWDPZJVCC-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
4.3996 -3.8218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9910 -5.0807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7412 -4.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9461 -4.1348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4000 -4.7394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6546 -5.5168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4491 -5.6833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0626 -4.3039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8064 -5.0781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3482 -5.6850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1464 -5.5190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3998 -4.7406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8562 -4.1370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3978 -3.0046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1047 -2.5945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1029 -1.7773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8133 -3.0016 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8098 -1.3672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3943 -1.3702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5183 -1.7743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5159 -2.5889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2236 -2.9959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9314 -2.5857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9271 -1.7643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2187 -1.3610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6324 -1.3517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3425 -1.7563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6917 -6.1276 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 9 1 0
8 1 1 0
1 3 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
1 14 1 0
14 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
16 19 1 0
18 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
24 26 1 0
26 27 1 0
11 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.34Molecular Weight (Monoisotopic): 436.0786AlogP: 5.22#Rotatable Bonds: 5Polar Surface Area: 34.47Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.77CX LogD: 4.77Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.43Np Likeness Score: -1.44
References 1. Cheng HWA, Sokias R, Werry EL, Ittner LM, Reekie TA, Du J, Gao Q, Hibbs DE, Kassiou M.. (2019) First Nondiscriminating Translocator Protein Ligands Produced from a Carbazole Scaffold., 62 (17): [PMID:31419132 ] [10.1021/acs.jmedchem.9b00980 ]